Across Britain, tens of thousands of people live with chronic blood conditions that impose a quiet but persistent burden on daily life — affecting their capacity to cook a meal, manage their medication, or simply move around their homes with confidence. It is in recognition of precisely this kind of functional impairment, rather than diagnosis alone, that the Department for Work and Pensions administers Personal Independence Payment, a non-means-tested benefit that can be worth up to £748 every four weeks for those who qualify at the highest rates.
The DWP has recorded 10,014 active PIP claims across eighteen blood-condition categories in its most recent data, a figure that offers a useful, if partial, window into how the benefit system intersects with haematological illness. Those eighteen categories span a wide clinical range, from the relatively common — iron-deficiency anaemia and B12 or folate-deficiency anaemia — to rarer hereditary and clotting disorders such as haemophilia A, haemophilia B (Christmas disease), Von Willebrand’s disease, hereditary spherocytosis, thalassaemia, and glucose-6-phosphate dehydrogenase deficiency. The list also encompasses sickle cell anaemia, aplastic anaemia, polycythaemia, autoimmune thrombocytopaenic purpura, and several broader catch-all groupings for haemolytic, metabolic, platelet, and clotting disorders where the precise type is unspecified or unknown.
The rates themselves were uprated by 3.8 per cent in April 2026. PIP is divided into two components — daily living and mobility — each assessed at either a standard or enhanced level depending on the severity of functional limitation the claimant experiences. The standard daily living rate currently stands at £76.55 per week and the enhanced rate at £114.80, while the standard mobility rate is £30.20 and the enhanced rate £80.10. A claimant awarded the enhanced rate on both components would receive approximately £187 per week, reaching the £748 figure over a four-week payment cycle.
What the data cannot convey, and what the DWP is careful to emphasise, is that a diagnosis does not confer entitlement. The assessment process is centred on functional impact: how a condition affects an individual’s ability to perform specific everyday activities, including preparing food, washing and dressing, managing medication, and navigating the physical environment. The condition must also have caused those difficulties for at least three months and be expected to continue for at least nine months — a threshold designed to focus support on sustained rather than transient impairment.
Equally important is what the benefit does not depend upon. PIP is blind to income, savings, and employment status, which distinguishes it from means-tested welfare and makes it available to working people whose condition imposes significant daily costs regardless of their financial position. This design reflects a sound principle: that the additional expense of living with disability is not extinguished by earning a wage.
The DWP also makes clear that its enumerated list of blood conditions is not exhaustive. A person with a haematological condition not named in the eighteen categories may still qualify if their functional limitations are sufficiently severe, a reminder that the assessment framework is built around the individual rather than the diagnostic label. The £748 figure, compelling as it is as a headline, describes only the ceiling of what is possible; the actual award for any given claimant will reflect their particular circumstances, assessed on their merits. Sound policy, in this instance, resists the temptation to reduce complex human need to a simple list.